Ping An Biomedical (PASW) News
NASDAQ: PASWConsumer DiscretionaryApparelUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PASW news summary
We found 4 recent headlines mentioning Ping An Biomedical (PASW): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Business Insider. PASW is making an outsized move today, down 10.32% at $1.13, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies", was published by Business Insider on Nov 4, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Ping An Biomedical headlines
- Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify" style="text-align:justify;">HONG KONG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ping An…Business Insider
- Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell TechnologiesThe patent acquisition is intended to support the Company’s longer-term healthcare and biomedical research and development strategy.GlobeNewswire
- Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property PortfolioPing An Biomedical (NASDAQ: PASW) signs LOI to acquire 3 tumor cell-related patents for $2–2.5M to build a core oncology and biotech IP portfolio.GlobeNewswire
- Ping An Biomedical Announces 1-for-40 Reverse Stock SplitPing An Bio approved a 1-for-40 reverse stock split; its Class A shares are set to trade on a split-adjusted basis Oct. 23 under PASW.GlobeNewswire